Anti-human IgA mAb (MT20), ALP 3860-9A-1000 from Mabtech AB

Product Specs
ItemAnti-human IgA mAb (MT20), ALP
CompanyMabtech AB
Price Pricing Info Supplier Page View Company Product Page
Catalog Number3860-9A-1000
Reactivityhuman
Formatenzyme-conjugated
ApplicationsELISA
Quantity1 ml
TargetIgA
Conjugate/TagALP
NCBI Full Gene Nameimmunoglobulin heavy constant alpha 2 (A2m marker), immunoglobulin heavy constant alpha 1
NCBI Gene AliasesIgA1, A2M
ClonalityMonoclonal
CloneMT20
HostRat
IsotypeIgG1
ComponentsMT20, ALP conjugated, supplied in 0.1 M Tris buffer with 0.002% Kathon CG

Box 1233

Nacka Strand, SE-131 28

Sweden

Phone: +46 8 716 27 00
+46 8 716 27 01

(1) Systems serology detects functionally distinct coronavirus antibody features in children and elderlyNature CommunicationsDecember 1, 2021Kevin J. Selva et al.#109-035-098; Jackson ImmunoResearch) or alkaline phosphate-conjugated rat anti-human IgA (mAb MT20; #3860-9A-1000; MabTech), was used and developed with TMB (Sigma) substrate for IgG or pNPP (Sigma) for IgA. For IgM,

(2) Safety and immunogenicity of an oral tablet norovirus vaccine, a phase I randomized, placebo-controlled trialJCI insightJuly 12, 2018Kim L, Liebowitz D, Lin K, Kasparek K, Pasetti MF, Garg SJ, Gottlieb K, Trager G, Tucker SN.

(4) Characteristics of the specific humoral response in patients with advanced solid tumors after active immunotherapy with a VEGF vaccine, at different antigen doses and using two distinct adjuvantsBMC immunologyJuly 26, 2017Sánchez Ramírez J, Morera Díaz Y, Bequet-Romero M, Hernández-Bernal F, Selman-Housein Bernal KH, de la Torre Santos A, Santiesteban Álvarez ER, Martín Bauta Y, Bermúdez Badell CH, de la Torre Pupo J, et al.

(5) Relationship between the IgA antibody response against Streptococcus mutans GbpB and severity of dental caries in childhoodArchives of oral biologyJuly 1, 2016Colombo NH, Pereira JA, da Silva ME, Ribas LF, Parisotto TM, Mattos-Graner Rde O, Smith DJ, Duque C.

(6) Calcineurin inhibitors dampen humoral immunity by acting directly on naive B cellsClinical and experimental immunologyJune 1, 2015De Bruyne R, Bogaert D, De Ruyck N, Lambrecht BN, Van Winckel M, Gevaert P, Dullaers M.

Nature Communications